These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15470083)

  • 1. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.
    Beazely MA; Alan JK; Watts VJ
    Mol Pharmacol; 2005 Jan; 67(1):250-9. PubMed ID: 15470083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
    Beazely MA; Watts VJ
    Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.
    Beazely MA; Watts VJ
    Biochem Pharmacol; 2005 Jul; 70(1):113-20. PubMed ID: 15885660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
    Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
    Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
    Lembo PM; Albert PR
    Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
    Johnson RA; Toews ML
    Mol Pharmacol; 1990 Feb; 37(2):296-303. PubMed ID: 1689454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-induced Ras protein 1 negatively regulates protein kinase C delta: implications for adenylyl cyclase 2 signaling.
    Nguyen CH; Watts VJ
    Mol Pharmacol; 2006 May; 69(5):1763-71. PubMed ID: 16489124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylyl cyclase-cAMP system inhibits thrombin-induced HSP27 in vascular smooth muscle cells.
    Hirade K; Tanabe K; Niwa M; Ishisaki A; Nakajima K; Nakamura M; Sugiyama T; Katagiri Y; Kato K; Kozawa O
    J Cell Biochem; 2005 Feb; 94(3):573-84. PubMed ID: 15543559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin and phorbol esters potentiate Gs-mediated cAMP formation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII.
    Haslauer M; Baltensperger K; Porzig H
    Mol Pharmacol; 1998 May; 53(5):837-45. PubMed ID: 9584209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activators of protein kinase C but not of phospholipase C modulate adenylate cyclase-responses of normal pig epidermis.
    Iizuka H; Takahashi H; Ishida-Yamamoto A; Hashimoto Y
    Epithelial Cell Biol; 1995; 4(1):35-41. PubMed ID: 8563794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
    Chern Y; Chiou JY; Lai HL; Tsai MH
    Mol Pharmacol; 1995 Jul; 48(1):1-8. PubMed ID: 7623763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.
    Varga EV; Rubenzik MK; Stropova D; Sugiyama M; Grife V; Hruby VJ; Rice KC; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Jul; 306(1):109-15. PubMed ID: 12660310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
    Qian H; Pipolo L; Thomas WG
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C regulates the activity and stability of serotonin N-acetyltransferase.
    Choi BH; Chae HD; Park TJ; Oh J; Lim J; Kang SS; Ha H; Kim KT
    J Neurochem; 2004 Jul; 90(2):442-54. PubMed ID: 15228600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
    Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
    Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
    Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.